发明人刘建华,沈红梅,李文辉. "Method for the Synthesis of 479683-64-2
A2EXW95647
CP-809101
UNII-A2EXW95647
Pyrazine, 2-((3-chlorophenyl)methoxy)-6-(1-piperazinyl)-
6'-(3-Chlorobenzyloxy)-3,4,5,6-tetrahydro-2H-(1,2')bipyrazine" [P]. 中国发明专利, 专利号 CN 114150726 A, 授权公告日 2024-04-25.
发明人陈志强,周伟,沈红梅. "A Process for Preparing High-Purity 479683-64-2
A2EXW95647
CP-809101
UNII-A2EXW95647
Pyrazine, 2-((3-chlorophenyl)methoxy)-6-(1-piperazinyl)-
6'-(3-Chlorobenzyloxy)-3,4,5,6-tetrahydro-2H-(1,2')bipyrazine" [P]. 中国发明专利, 专利号 CN 116041249 B, 授权公告日 2019-06-06.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of CP-809,101 fumarate in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 2095, 884-906.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of CP-809,101 fumarate as an Impurity". Anal. Chim. Acta, 2023, 2410, 72-81.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 479683-64-2
A2EXW95647
CP-809101
UNII-A2EXW95647
Pyrazine, 2-((3-chlorophenyl)methoxy)-6-(1-piperazinyl)-
6'-(3-Chlorobenzyloxy)-3,4,5,6-tetrahydro-2H-(1,2')bipyrazine Using HRMS and NMR". Sci. Total Environ., 2018, 2467, (1), 4227-4256.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate CP-809,101 fumarate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2013, 1330, 1157-1180.